CurrentEndo
Get Weekly

CurrentEndo coverage · page 11 of 55

Diabetes, Obesity and Metabolism

Briefs 401–440 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Effect of Tirzepatide on Health‐Related Quality of Life in Japanese Patients With Obesity Disease: Patient‐Reported Outcomes From the SURMOUNT ‐J Study

    Secondary analysisObesity

  2. Diabetes Obes Metab

    Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes

    Cross-sectional studyT2D & other

  3. Diabetes Obes Metab

    Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Large‐Scale Plasma Proteomics Improves Prediction of Major Adverse Liver Outcomes in Individuals With MASLD

    Cohort studyLipids & liver

  5. Diabetes Obes Metab

    Social Determinants of Health Reveal Heterogeneity in Associations Between AHA PREVENT Cardiovascular Disease Risk Equations and Mortality and Provide Incremental Discrimination for Mortality in US Adults

    Cohort study

  6. Diabetes Obes Metab

    The Evolving Role of High‐Sensitivity C‐Reactive Protein for Mortality Prediction Across the Spectrum of Cardiovascular–Kidney–Metabolic Syndrome

    Cohort study

  7. Diabetes Obes Metab

    Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England

    Cohort studyT2D & other

  8. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation

    Research articleObesity

  9. Diabetes Obes Metab

    Pre‐Pregnancy GLP ‐ 1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry‐Over Versus Post‐Discontinuation Metabolic Rebound in a Multinational Federated Cohort

    Cohort studyDiabetes in pregnancy

  10. Diabetes Obes Metab

    Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study

    Cohort studyT2D & other

  11. Diabetes Obes Metab

    Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study

    Cohort studyBone & mineral

  12. Diabetes Obes Metab

    GLP ‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

    Cohort study

  13. Diabetes Obes Metab

    Suboptimal LDL ‐Cholesterol Control Under the 2019 ESC / EAS Dyslipidemia Guidelines: Results From the Nationwide TEMD ‐2 Study in Type 2 Diabetes

    Cross-sectional studyT2D & other

  14. Diabetes Obes Metab

    Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon‐Like Peptide‐1 Receptor Agonist Versus a Fixed‐Ratio Combination Therapy: A Japanese Database Study

    Cohort studyT2D & other

  15. Diabetes Obes Metab

    Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review

    Research articleTechnology

  16. Diabetes Obes Metab

    Clinical Characteristics of Users of Weight Loss Drugs: Population‐Based Case–Control Study

    Case-control studyObesity

  17. Diabetes Obes Metab

    Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States

    Research articleTechnology

  18. Diabetes Obes Metab

    Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses

    Secondary analysisT2D & other

  19. Diabetes Obes Metab

    A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion

    Cross-sectional studyTechnology

  20. Diabetes Obes Metab

    Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study

    Cohort studyComplications

  21. Diabetes Obes Metab

    Efficacy and Safety of T Cell‐Targeted Immunotherapy in Newly Diagnosed Type 1 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysisT1D

  22. Diabetes Obes Metab

    Higher Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Associated With Reduced Risk of Prediabetes

    Cross-sectional studyT2D & other

  23. Diabetes Obes Metab

    Pharmacological Treatment for Gestational Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of 71 Randomised Controlled Trial

    Meta-analysisDiabetes in pregnancy

  24. Diabetes Obes Metab

    Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes

    Secondary analysisT2D & other

  25. Diabetes Obes Metab

    Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease

    Cohort studyT2D & other

  26. Diabetes Obes Metab

    Sitagliptin, Metformin and Glimepiride Fixed‐Dose Combination Compared to Co‐Administration of Metformin and High‐Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Double‐Dummy, Phase 3 Clinical Study

    Randomized controlled trialT2D & other

  27. Diabetes Obes Metab

    Association Between Maternal Diabetes and the Risk of Cancers in Mother‐Offspring: A Meta‐Analysis of 44.9 Million Pregnancies

    Meta-analysisDiabetes in pregnancy

  28. Diabetes Obes Metab

    Efficacy and Safety of Pregabalin and Alpha‐Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open‐Label, Non‐Inferiority, Phase IV Clinical Trial and Subgroup Analysis ( OPTIMUM Study )

    Randomized controlled trialComplications

  29. Diabetes Obes Metab

    High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics

    Cross-sectional studyLipids & liver

  30. Diabetes Obes Metab

    Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity

    Research articleObesity

  31. Diabetes Obes Metab

    Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood

    Cohort studyObesity

  32. Diabetes Obes Metab

    Association of Metabolic Vulnerability Index With Incident Type 2 Diabetes in General Population and All‐Cause Mortality in Patients With Diabetes: A Cohort Study Based on UK Biobank

    Cohort studyT2D & other

  33. Diabetes Obes Metab

    Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials

    Meta-analysisObesity

  34. Diabetes Obes Metab

    Six‐Month Real‐World Effectiveness, Persistence and Safety of Low‐to‐Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study

    Cohort studyObesity

  35. Diabetes Obes Metab

    Accelerometer‐Derived ‘Weekend Warrior’ Physical Activity Pattern and Microvascular Risk in Individuals With Type 2 Diabetes and Prediabetes

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis

    Secondary analysisT2D & other

  37. Diabetes Obes Metab

    Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States ( SMILE )

    Cohort studyObesity

  38. Diabetes Obes Metab

    Serum IGF ‐1 and the Risk of Cardio‐Kidney Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease

    Cohort studyLipids & liver

  39. Diabetes Obes Metab

    Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles

    Cross-sectional studyT2D & other

  40. Diabetes Obes Metab

    Comparative Effects of Different Exercise Modalities on Circulating Adipokines and Inflammatory Cytokines in Adults With Type 2 Diabetes: A Network Meta‐Analysis

    Meta-analysisT2D & other

All 2,200 Briefs in ExploreShowing Briefs 401–440 of 2,200, newest first